Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Abiomed Inc (ABMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,567,262
  • Shares Outstanding, K 45,086
  • Annual Sales, $ 593,750 K
  • Annual Income, $ 112,170 K
  • 60-Month Beta 0.33
  • Price/Sales 16.07
  • Price/Cash Flow 90.41
  • Price/Book 13.30

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 1.06
  • Number of Estimates 7
  • High Estimate 1.13
  • Low Estimate 1.03
  • Prior Year 0.80
  • Growth Rate Est. (year over year) +32.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
244.08 +5.11%
on 04/18/19
348.27 -26.33%
on 03/21/19
-76.69 (-23.01%)
since 03/18/19
3-Month
244.08 +5.11%
on 04/18/19
364.31 -29.58%
on 02/19/19
-77.18 (-23.13%)
since 01/18/19
52-Week
244.08 +5.11%
on 04/18/19
459.75 -44.20%
on 10/01/18
-51.07 (-16.60%)
since 04/18/18

Most Recent Stories

More News
TMO or ABMD: Which Is the Better Value Stock Right Now?

TMO vs. ABMD: Which Stock Is the Better Value Option?

ABMD : 256.56 (+2.02%)
TMO : 259.78 (+0.88%)
Abiomed (ABMD) Outpaces Stock Market Gains: What You Should Know

Abiomed (ABMD) closed at $256.28 in the latest trading session, marking a +1.9% move from the prior day.

ABMD : 256.56 (+2.02%)
After Yesterday's Decline of 4.64%, Abiomed Inc Offers Investors Better Value

Abiomed Inc (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $253.60 to a high of $261.08. Yesterday, the shares fell 4.6%, which took the trading range below the 3-day low of $265.57...

ABMD : 256.56 (+2.02%)
Abiomed (ABMD) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Abiomed (ABMD) closed at $270.08, marking a -0.67% move from the previous day.

ABMD : 256.56 (+2.02%)
Why Abiomed (ABMD) Could Beat Earnings Estimates Again

Abiomed (ABMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

ABMD : 256.56 (+2.02%)
Will Instruments Drive Intuitive Surgical (ISRG) Q1 Earnings?

Intuitive Surgical's (ISRG) Systems and Services revenues are likely to boost Q1 results.

SYK : 180.26 (+0.01%)
ABMD : 256.56 (+2.02%)
ISRG : 528.06 (+0.58%)
PKI : 94.15 (+0.60%)
Abiomed Fourth Quarter Fiscal 2019 Earnings and Conference Call Notification

Abiomed, Inc. (NASDAQ: ABMD) announced that on Thursday, May 2, 2019, the Company will release financial results for the fourth quarter of fiscal 2019. The Company will host a conference...

ABMD : 256.56 (+2.02%)
Abiomed Inc Falls 3.20% on Heavy Volume: Watch For Potential Rebound

Abiomed Inc (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $271.55 to a high of $277.98. Yesterday, the shares fell 3.2%, which took the trading range below the 3-day low of $278.21...

ABMD : 256.56 (+2.02%)
Research Report Identifies Chimerix, Evolent Health, ABIOMED, Syndax Pharmaceuticals, Independence Realty Trust, and Selecta Biosciences with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Chimerix, Inc. (NASDAQ:CMRX),...

EVH : 13.23 (+4.17%)
ABMD : 256.56 (+2.02%)
SNDX : 6.29 (+0.32%)
IRT : 10.30 (+1.78%)
SELB : 2.30 (-0.43%)
CMRX : 2.62 (+0.38%)
The Zacks Analyst Blog Highlights: Heidrick & Struggles International, ABIOMED, SeaWorld Entertainment, Darden Restaurants and AAON

The Zacks Analyst Blog Highlights: Heidrick & Struggles International, ABIOMED, SeaWorld Entertainment, Darden Restaurants and AAON

AAON : 47.59 (+0.27%)
SEAS : 23.38 (-1.52%)
ABMD : 256.56 (+2.02%)
DRI : 116.87 (+2.14%)
HSII : 39.86 (-0.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade ABMD with:

Business Summary

Abiomed, Inc. is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufactures and markets proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing...

See More

Key Turning Points

2nd Resistance Point 265.56
1st Resistance Point 261.06
Last Price 256.56
1st Support Level 248.07
2nd Support Level 239.58

See More

52-Week High 459.75
Fibonacci 61.8% 377.36
Fibonacci 50% 351.92
Fibonacci 38.2% 326.47
Last Price 256.56
52-Week Low 244.08

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar